Document is current

Any future updates will be listed below

Could the TAE score predicting the prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors be better if certain revisions are made?

Crossref DOI link: https://doi.org/10.1007/s12072-025-10789-4

Published Online: 2025-02-20

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark